Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy

Souhei Ohguchi, Harushige Nakatsukasa, Toshihiro Higashi, Kozo Ashida, Kazuhiro Nouso, Masahiko Ishizaki, Naoki Hino, Yoshiyuki Kobayashi, Shuji Uematsu, Takao Tsuji

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either α-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular distribution of AFP and albumin gene transcripts was studied in 25 cases of surgically removed human HCCs. AFP gene expression was observed in HCC nodules of 13 cases. The expression in HCC was heterogeneous, and the distribution of the transcripts was mostly sparse and spotty. The higher the serum AFP levels, the larger population of the AFP-expressing HCC cells tended to reflect. In noncancerous liver, a slight AFP expression was found by Northern blot analysis, but the transcripts were not detected in the liver sections. In contrast, albumin expression was found in all HCCs as well as in noncancerous hepatocytes. In HCC, the transcripts for albumin were distributed in cancer cells, and the expression varied with nodules. There were more albumin-expressing cancer cells than the AFP-expressing cells. Albumin expression was retained even in poorly differentiated HCC, although the intensity of the signal was not as strong as in more-differentiated HCCs. Metastatic HCC nodules revealed transcripts for both AFP and albumin genes, and those were clearly recognized in the lung tissue. These results suggest that, for gene therapy for HCCs, neither AFP nor albumin are ideal options for targeting HCC cells. AFP-TRS may be used as a transcriptional regulator in selected cases in which AFP gene expression is observed in the cancer nodules. The serum AFP level appears to be an important indicator in selecting cases. Albumin-TRS in conjunction with retroviral vector might be used in limited cases such as HCCs with no AFP expression. However, careful consideration must be taken, because albumin is constitutively expressed in normal hepatocytes, and AFP-expressing nonmalignant progenitor cells possibly exist.

Original languageEnglish
Pages (from-to)599-607
Number of pages9
JournalHepatology
Volume27
Issue number2
DOIs
Publication statusPublished - 1998

Fingerprint

Fetal Proteins
Gene Targeting
Genetic Therapy
Albumins
Hepatocellular Carcinoma
Genes
Hepatocytes
Neoplasms
Gene Expression
Liver
Serum
Northern Blotting
Stem Cells

ASJC Scopus subject areas

  • Hepatology

Cite this

Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas : Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. / Ohguchi, Souhei; Nakatsukasa, Harushige; Higashi, Toshihiro; Ashida, Kozo; Nouso, Kazuhiro; Ishizaki, Masahiko; Hino, Naoki; Kobayashi, Yoshiyuki; Uematsu, Shuji; Tsuji, Takao.

In: Hepatology, Vol. 27, No. 2, 1998, p. 599-607.

Research output: Contribution to journalArticle

Ohguchi, Souhei ; Nakatsukasa, Harushige ; Higashi, Toshihiro ; Ashida, Kozo ; Nouso, Kazuhiro ; Ishizaki, Masahiko ; Hino, Naoki ; Kobayashi, Yoshiyuki ; Uematsu, Shuji ; Tsuji, Takao. / Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas : Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. In: Hepatology. 1998 ; Vol. 27, No. 2. pp. 599-607.
@article{8cbd791fc5a1491ab3ca601eefb44c18,
title = "Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy",
abstract = "For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either α-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular distribution of AFP and albumin gene transcripts was studied in 25 cases of surgically removed human HCCs. AFP gene expression was observed in HCC nodules of 13 cases. The expression in HCC was heterogeneous, and the distribution of the transcripts was mostly sparse and spotty. The higher the serum AFP levels, the larger population of the AFP-expressing HCC cells tended to reflect. In noncancerous liver, a slight AFP expression was found by Northern blot analysis, but the transcripts were not detected in the liver sections. In contrast, albumin expression was found in all HCCs as well as in noncancerous hepatocytes. In HCC, the transcripts for albumin were distributed in cancer cells, and the expression varied with nodules. There were more albumin-expressing cancer cells than the AFP-expressing cells. Albumin expression was retained even in poorly differentiated HCC, although the intensity of the signal was not as strong as in more-differentiated HCCs. Metastatic HCC nodules revealed transcripts for both AFP and albumin genes, and those were clearly recognized in the lung tissue. These results suggest that, for gene therapy for HCCs, neither AFP nor albumin are ideal options for targeting HCC cells. AFP-TRS may be used as a transcriptional regulator in selected cases in which AFP gene expression is observed in the cancer nodules. The serum AFP level appears to be an important indicator in selecting cases. Albumin-TRS in conjunction with retroviral vector might be used in limited cases such as HCCs with no AFP expression. However, careful consideration must be taken, because albumin is constitutively expressed in normal hepatocytes, and AFP-expressing nonmalignant progenitor cells possibly exist.",
author = "Souhei Ohguchi and Harushige Nakatsukasa and Toshihiro Higashi and Kozo Ashida and Kazuhiro Nouso and Masahiko Ishizaki and Naoki Hino and Yoshiyuki Kobayashi and Shuji Uematsu and Takao Tsuji",
year = "1998",
doi = "10.1002/hep.510270239",
language = "English",
volume = "27",
pages = "599--607",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas

T2 - Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy

AU - Ohguchi, Souhei

AU - Nakatsukasa, Harushige

AU - Higashi, Toshihiro

AU - Ashida, Kozo

AU - Nouso, Kazuhiro

AU - Ishizaki, Masahiko

AU - Hino, Naoki

AU - Kobayashi, Yoshiyuki

AU - Uematsu, Shuji

AU - Tsuji, Takao

PY - 1998

Y1 - 1998

N2 - For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either α-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular distribution of AFP and albumin gene transcripts was studied in 25 cases of surgically removed human HCCs. AFP gene expression was observed in HCC nodules of 13 cases. The expression in HCC was heterogeneous, and the distribution of the transcripts was mostly sparse and spotty. The higher the serum AFP levels, the larger population of the AFP-expressing HCC cells tended to reflect. In noncancerous liver, a slight AFP expression was found by Northern blot analysis, but the transcripts were not detected in the liver sections. In contrast, albumin expression was found in all HCCs as well as in noncancerous hepatocytes. In HCC, the transcripts for albumin were distributed in cancer cells, and the expression varied with nodules. There were more albumin-expressing cancer cells than the AFP-expressing cells. Albumin expression was retained even in poorly differentiated HCC, although the intensity of the signal was not as strong as in more-differentiated HCCs. Metastatic HCC nodules revealed transcripts for both AFP and albumin genes, and those were clearly recognized in the lung tissue. These results suggest that, for gene therapy for HCCs, neither AFP nor albumin are ideal options for targeting HCC cells. AFP-TRS may be used as a transcriptional regulator in selected cases in which AFP gene expression is observed in the cancer nodules. The serum AFP level appears to be an important indicator in selecting cases. Albumin-TRS in conjunction with retroviral vector might be used in limited cases such as HCCs with no AFP expression. However, careful consideration must be taken, because albumin is constitutively expressed in normal hepatocytes, and AFP-expressing nonmalignant progenitor cells possibly exist.

AB - For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either α-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular distribution of AFP and albumin gene transcripts was studied in 25 cases of surgically removed human HCCs. AFP gene expression was observed in HCC nodules of 13 cases. The expression in HCC was heterogeneous, and the distribution of the transcripts was mostly sparse and spotty. The higher the serum AFP levels, the larger population of the AFP-expressing HCC cells tended to reflect. In noncancerous liver, a slight AFP expression was found by Northern blot analysis, but the transcripts were not detected in the liver sections. In contrast, albumin expression was found in all HCCs as well as in noncancerous hepatocytes. In HCC, the transcripts for albumin were distributed in cancer cells, and the expression varied with nodules. There were more albumin-expressing cancer cells than the AFP-expressing cells. Albumin expression was retained even in poorly differentiated HCC, although the intensity of the signal was not as strong as in more-differentiated HCCs. Metastatic HCC nodules revealed transcripts for both AFP and albumin genes, and those were clearly recognized in the lung tissue. These results suggest that, for gene therapy for HCCs, neither AFP nor albumin are ideal options for targeting HCC cells. AFP-TRS may be used as a transcriptional regulator in selected cases in which AFP gene expression is observed in the cancer nodules. The serum AFP level appears to be an important indicator in selecting cases. Albumin-TRS in conjunction with retroviral vector might be used in limited cases such as HCCs with no AFP expression. However, careful consideration must be taken, because albumin is constitutively expressed in normal hepatocytes, and AFP-expressing nonmalignant progenitor cells possibly exist.

UR - http://www.scopus.com/inward/record.url?scp=17344374394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344374394&partnerID=8YFLogxK

U2 - 10.1002/hep.510270239

DO - 10.1002/hep.510270239

M3 - Article

C2 - 9462663

AN - SCOPUS:17344374394

VL - 27

SP - 599

EP - 607

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -